JOINT POSITION PAPER FROM EXCIPIENT …
1 JOINT POSITION PAPER FROM EXCIPIENT MANUFACTURERS, 2 DRUG PRODUCT MANUFACTURERS AND USP ON 3 PHARMACEUTICAL EXCIPIENT 4 TESTING AND CONTROL STRATEGIES; 5 BASED ON A 6 PQRI SURVEY AND WORKSHOP 7 8 Authors: Brian Carlin, Dale Carter, Gregory Larner, Kevin Moore, Barry Rothman, …
Download JOINT POSITION PAPER FROM EXCIPIENT …
Information
Domain:
Source:
Link to this page:
Documents from same domain
Regulatory perspectives on CQAs, CPPs, and Risk …
pqri.orgGlobal Regulatory Affairs Regulatory perspectives on CQAs, CPPs, and Risk Analyses for Combination Products. 3rd FDA/PQRI Conference on Advancing Product Quality
Hazard & Operability Analysis (HAZOP) 1 Overview
pqri.orgManufacturing Technology Committee – Risk Management Working Group Risk Management Training Guides Hazard & Operability Analysis (HAZOP) Page 1 of 9 1 Overview Hazard and Operability Analysis (HAZOP) is a …
Failure Modes and Effects Analysis Guide
pqri.orgManufacturing Technology Committee – Risk Management Working Group Risk Management Training Guides Failure Modes and Effects Analysis Guide 1 Overview Failure Modes and Effects Analysis (FMEA) is …
CMC Regulatory Considerations for …
pqri.orgCMC Regulatory Considerations for Oligonucleotide Drug Products: FDA Perspective Mohan Sapru, M.S., Ph.D. CMC Lead for Cardiovascular and Renal Products
ICH Q12 : A Unique Opportunity to Realize 21st …
pqri.orgICH Q12 : A Unique Opportunity to Realize 21st Century Quality Vision . Moheb M. Nasr . 3rd FDA/PQRI Conference . March 22, 2017
INTRODUCTION TO POLYMER ADDITIVES AND …
pqri.orgINTRODUCTION TO POLYMER ADDITIVES AND STABILIZATION Bobbijo van Beusichem, Ph.D., Senior Staff Scientist, Expert Services, Michael A. Ruberto, Ph.D., Head of Regulatory Services, NAFTA, Expert Services
Thresholds and Best Practices for Extractable and …
pqri.orgOverview of Thresholds and Best Practices for Extractable and Leachables(L&E) 3rd PQRI/FDA Conference on Advancing Product Quality Washington DC, 22 …
Harmonization of Requirements Between ICH Q3D …
pqri.orgHarmonization of Requirements Between ICH Q3D and Pharmacopeias Kahkashan Zaidi, USP PQRI/USP Workshop on Elemental Impurities March 31 – April 1, 2015 USP Rockville, Maryland
European reflections on reviewing NDAs and …
pqri.orgEuropean reflections on reviewing NDAs and ANDAs for ICH Q3D elemental impurity compliance Diana van Riet-Nales, Medicines Evaluation Board/NL
Recommendations for the Assessment of Blend …
pqri.orgRecommendations for the Assessment of Blend and Content Uniformity: Modern Approaches to Sampling and Testing James K. Drennen, III drennen@duq.edu
Related documents
In Vitro Release Testing of Semi-Solid Dosage Forms
www.dissolutiontech.com52 I BACKGROUND n vitro release testing (IVRT) is used to monitor the release and diffusion of drug products from semisolid dosage forms (1–11) and has long been considered a valuable tool in formulation development.
<1151> PHARMACEUTICAL DOSAGE FORMS - …
www.drugfuture.com766 〈1151〉 Pharmaceutical Dosage Forms / General Information USP 35 Figure 1. Compendial Taxonomy for Pharmaceutical Dosage Forms. volumes recommended in the accompanying table are usu- Identification—Identification tests are discussed in the
USP Reference Standards - Eurolab SA
www.eurolabsa.com.ar“Analytical Procedures and Methods Validation” –Chemistry, Manufacturing, and Controls Documentation, August 2000 Reference Standards Types of Standards
Autoclaves Qualification & Validation - gmpua.com
www.gmpua.com2 of 39 Autoclaves: Qualification & Validation Holger Fabritz - Expertentreff 14. September 2007 in Baden Contents • Types of autoclaves • Regulatory Aspects • GMP Risk Analysis • URS / FDS • Design Qualification • Installation Qualification / Operational Qualification • Performance Qualification / Process Validation • Responsibilities • …
VALIDATION OF COMPENDIAL PROCEDURES
www.ofnisystems.com2 〈1225〉 Validation of Compendial Procedures / General Information USP 36 PRECISION Analytical Performance Characteristics Definition—The precision of an analytical procedure is
LOT O0G356 - validation.co.jp
www.validation.co.jpPage 1 of 2 17-Jun-2008 USP Certificate Prednisone LOT O0G356 Molecular Formula Molecular Weight CAS Number LABEL TEXT USP certifies that the USP Reference Standards Committee, in accordance with their rules and procedures,